The Role of Deep Learning Artificial Intelligence Technologies in Personalized Treatment of Multiple Sclerosis

Multiple sclerosis (MS) is a neurodegenerative disorder characterized by varying symptoms and disease progression, making personalized treatment strategies crucial for optimizing patient outcomes. In recent years, the integration of deep learning (DL) within the larger set of artificial intelligence (AI) technologies into healthcare has sparked significant interest in the scientific community. This literature review aims to explore the following question: “Are DL AI technologies vital for the future of personalized treatment of MS?”